Johnson & Johnson's expenditure on research and development from 2005 to 2018
(in million U.S. dollars)
Johnson & Johnson's expenditure on research and development 2005-2018
Johnson & Johnson (J&J) is a leading global diversified health and pharmaceutical company in many regards. It’s research and development (R&D) programs have received increasing funding from the company. In 2018, J&J expended 10.8 billion U.S. dollars on research and development programs. This is a significant increase from 2005 when the company spent 6.5 billion dollars on R&D.

Johnson & Johnson’s global positioning

Globally there are several top pharmaceutical companies, however Johnson & Johnson stand out about many of them with research and development being a top priority for the company. Therefore, it is no surprise that J&J is among the top three pharmaceutical companies based on its R&D spending. Johnson & Johnson also has one of the largest current research and development pipelines among global pharmaceutical companies.

The importance of pharmaceutical R&D

Among all industries, pharmaceuticals and biotechnology are among those with the largest investments in research and development. Pharmaceutical research and development is the process in which pharmaceutical companies apply research to generate new pharmaceutical products which in most cases involves clinical trials. The number of drugs being researched and developed globally has never been higher than in recent years. However, the success rate for new drugs in development is only around 10 percent.
Johnson & Johnson's expenditure on research and development from 2005 to 2018
(in million U.S. dollars)
Expenditure in million U.S. dollars
201810,775
201710,554
20169,095
20159,046
20148,494
20138,183
20127,665
20117,548
20106,844
20096,986
20087,577
20077,680
20067,125
20056,462
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2005 to 2018

Open this statistic in...
Johnson & Johnson's expenditure on research and development 2005-2018
Johnson & Johnson (J&J) is a leading global diversified health and pharmaceutical company in many regards. It’s research and development (R&D) programs have received increasing funding from the company. In 2018, J&J expended 10.8 billion U.S. dollars on research and development programs. This is a significant increase from 2005 when the company spent 6.5 billion dollars on R&D.

Johnson & Johnson’s global positioning

Globally there are several top pharmaceutical companies, however Johnson & Johnson stand out about many of them with research and development being a top priority for the company. Therefore, it is no surprise that J&J is among the top three pharmaceutical companies based on its R&D spending. Johnson & Johnson also has one of the largest current research and development pipelines among global pharmaceutical companies.

The importance of pharmaceutical R&D

Among all industries, pharmaceuticals and biotechnology are among those with the largest investments in research and development. Pharmaceutical research and development is the process in which pharmaceutical companies apply research to generate new pharmaceutical products which in most cases involves clinical trials. The number of drugs being researched and developed globally has never been higher than in recent years. However, the success rate for new drugs in development is only around 10 percent.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Johnson & Johnson"
  • Global positioning
  • Revenue and income
  • Segments
  • Miscellaneous
The most important statistics
  • Forecasts
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.